Toggle light / dark theme

Prevalence and Factors Associated With Atrial Fibrillation Among Young Patients With Ischemic Stroke

Stra8 links neuronal activity to inhibitory circuit protection in the adult mouse brain.


Huang et al. show that Stra8, a gene previously thought to be germline specific, is expressed in the adult mouse hippocampus in an activity-dependent manner. Stra8 protects neuronal integrity and cognition by regulating neuromodulator genes and preserving inhibitory circuit function.

How natural daylight can help people with diabetes improve blood sugar levels

People with type 2 diabetes may be able to improve their blood sugar by doing something as simple as sitting by a window for a few hours each day. In a study published in Cell Metabolism, scientists showed that natural daylight helps maintain healthy glucose levels.

Daylight is known to be a mood enhancer and also beneficial for our health. However, according to the research team, most people living in Western societies typically stay indoors around 80% to 90% of the time under artificial light, which is not as bright or dynamic as sunlight. This is important because the human body operates on circadian rhythms, internal 24-hour clocks that orchestrate a range of biological processes, such as digestion and temperature regulation. These are synchronized by light, and a lack of natural light is a risk factor for type 2 diabetes.

Previous studies have shown that artificial light at night disrupts these rhythms and that daylight outdoors can improve the body’s response to insulin, which helps control blood sugar levels. But no prior research examined how natural light entering a window affects people with diabetes.

Prodrug nanoplatform for triggering ferroptosis to eliminate senescent cells in age-associated pathologies

Accumulation of senescent cells is associated with age-related diseases. Here, the authors present a prodrug nanoplatform to trigger ferroptosis specifically and exclusively in senescent cells.

How common is Alzheimer’s? Blood-test study holds surprises

A Nature analysis of a major Norwegian study challenges existing estimates of Alzheimer’s prevalence, finding that 25% of people aged 85–89 have dementia with Alzheimer’s pathology — far higher than previous 7–13% estimates — while preclinical Alzheimer’s in younger seniors (70−74) occurs at only 8% versus earlier 22% estimates. Using blood biomarker pTau217 in 11,486 participants, researchers identified that 10% of over-70s had dementia, 10% had mild cognitive impairment, and 10% had preclinical Alzheimer’s, but warn that blood tests alone are insufficient for widespread screening due to potential harm from false positives. The discrepancies highlight how previous studies may have been skewed by selection bias, while demonstrating that blood-based biomarkers require careful interpretation and comprehensive clinical assessment.


A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to risk.

Physical and Cognitive Activities and Trajectories of AD Neuroimaging BiomarkersLongitudinal Analysis in the Mayo Clinic Study of Aging

Background and ObjectivesEngagement in physical and cognitive activities is associated with a decreased risk of mild cognitive impairment (MCI) and dementia, but the association with Alzheimer disease (AD) neuroimaging biomarkers is less clear. We thus…

Efficient site-specific integration of kilobase-length DNA fragments in plant cells via Kp03 recombinase

Employing this sensitive assay, we revealed that the integration efficiencies of the 9.9-kb attP-containing DNA donor in rice cells remained remarkably high at 80.5%, relative to the 3.4-kb attP-containing donor, which was set as the baseline for 100% integration efficiency (Figure 2 B). However, a significant decrease in recombination efficiency was observed for donor DNA exceeding 17 kb. The integration efficiency of the 17.4-kb attP-containing plasmid decreased to 42.5% (Figure 2 B), and for the 27.3-kb attP-containing plasmid, it further declined to 8.2% (Figure 2 B). Similar trends were observed in Arabidopsis, with recombination efficiencies of 51.4%, 26.5%, and 9.0% for the 9.9-, 17.4-, and 27.3-kb attP-containing donors, respectively (Figure 2 C). Furthermore, PCR amplification of the attL junctions confirmed that the donor attP sequences had indeed been recombined into the attB as expected (Figures 2 D and 2E). Collectively, these results demonstrate that the Kp03 system can efficiently mediate targeted insertion of large DNA donors up to 27.3 kb in plant cells.

Interestingly, in addition to donor size, we also observed that Kp03-mediated recombination efficiency is sensitive to temperature, exhibiting differential efficiency under varying thermal conditions (Figure S2).

Cardiovascular Disease Biomarker Deep Dive (Test #7 In 2025)

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/

This computer runs on living human brain cells | REUTERS

An Australian startup has unveiled the world’s first commercial biological computer (CL1), running on living human cells. CL1 is claimed to be capable of learning and adapting faster than standard silicon-based AI.

#News #ai #technology #futureofhealth #computer #braincells #Reuters #Newsfeed.

Read the story here:

👉 Subscribe: http://smarturl.it/reuterssubscribe.

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: / reuters.
Follow Reuters on Twitter: / reuters.
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

Non-Opioid “Pain Sponge” Therapy Stops Cartilage Loss and Eases Chronic Pain

A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional strategy for managing chronic pain while helping preserve joint tissue. The findings focus on SN

/* */